News
SVA
6.47
0.00%
0.00
Weekly Report: what happened at SVA last week (0323-0327)?
Weekly Report · 03/30 10:08
Weekly Report: what happened at SVA last week (0316-0320)?
Weekly Report · 03/23 10:04
Sinovac Biotech files initial beneficial ownership statement for VP of Quality and Production Li Jing
Reuters · 03/18 12:35
Sinovac Biotech files initial beneficial ownership statement for Chief Business Officer Yang Guang (Helen)
Reuters · 03/18 12:32
Sinovac Biotech files Form 3 initial beneficial ownership statement for COO Gao Qiang
Reuters · 03/18 12:30
Sinovac Biotech files Form 3 as CFO Wang Nan reports 355,000 common shares ownership
Reuters · 03/18 12:28
Sinovac Biotech Director Wang Yu Filed Initial Beneficial Ownership Statement
Reuters · 03/18 12:26
Sinovac Biotech files Form 3 initial beneficial ownership statement for Director Jiao Shuge
Reuters · 03/18 12:24
Sinovac Biotech Director Lo Yuk Lam Files Initial Beneficial Ownership Statement
Reuters · 03/18 12:22
Sinovac Biotech Director Qiu Yu Min Files Initial Beneficial Ownership Statement
Reuters · 03/18 12:20
Sinovac Biotech Ltd. Director Fu Shan files initial beneficial ownership statement
Reuters · 03/18 12:12
Sinovac Biotech Director Simon Anderson Files Initial Beneficial Ownership Statement
Reuters · 03/18 12:11
Sinovac Biotech CEO and Director Weidong Yin files initial beneficial ownership statement
Reuters · 03/18 12:09
Sinovac Biotech files Form 3 initial beneficial ownership statement for Director Andrew Y. Yan
Reuters · 03/18 12:07
Weekly Report: what happened at SVA last week (0309-0313)?
Weekly Report · 03/16 10:05
Weekly Report: what happened at SVA last week (0302-0306)?
Weekly Report · 03/09 10:05
Weekly Report: what happened at SVA last week (0223-0227)?
Weekly Report · 03/02 10:04
NASDAQ TRADE HALT CONTINUES <SVA.O> REASON NOT AVAILABLE AT 07:02 PM
Reuters · 02/28 00:02
NASDAQ TRADE HALT CONTINUES <SVA.O> REASON NOT AVAILABLE AT 07:50 PM
Reuters · 02/26 00:50
Weekly Report: what happened at SVA last week (0216-0220)?
Weekly Report · 02/23 10:04
More
Webull provides a variety of real-time SVA stock news. You can receive the latest news about Sinovac Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About SVA
Sinovac Biotech Ltd (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, hand foot and mouth disease (HFMD), seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine.